Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Lamarca

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2021
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild AsthmaHelen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
The Lancet. Respiratory Medicine|October 4, 2020
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Respiratory Research|April 27, 2011
Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary diseasePaul W Jones, Stephen I Rennard, Alvar Agusti, et al.
Drug Safety|February 6, 2021
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA StudiesJ Mark FitzGerald, Paul M O'Byrne, Eric D Bateman, et al.
Lancet (London, England)|June 5, 2025
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 studyAlice P Chen, Geraldine O'Sullivan Coyne, Pamela L Wolters, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2021
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild AsthmaHelen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
The Lancet. Respiratory Medicine|October 4, 2020
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Respiratory Research|April 27, 2011
Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary diseasePaul W Jones, Stephen I Rennard, Alvar Agusti, et al.
Drug Safety|February 6, 2021
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA StudiesJ Mark FitzGerald, Paul M O'Byrne, Eric D Bateman, et al.
Lancet (London, England)|June 5, 2025
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 studyAlice P Chen, Geraldine O'Sullivan Coyne, Pamela L Wolters, et al.
Pageof 3